Our mission
Optimize Healthcare Resource Distribution
We provide a series of professional support modules tailored to enable your product to achieve successful market entry (Market Access). As a requirement for some medical products and services to gain optimal reimbursement in Japan, Health Technology Assessment (HTA) or Cost-Effectiveness Analysis (CEA) may also need to be addressed.
Our services are supported by professional world class experts based in Japan, Europe and the Asia-Pacific who are skilled in developing high quality market access and cost effectiveness strategies for the Japan healthcare market. These services have been specifically designed for companies wanting to know where and how to get started, and most importantly, for companies wanting quick and effective results at a price they can afford.
All photography provided by Matt Day
HEOR
A strategic plan of evidence generation helps to communicate the real value of your product to the stakeholders. They are to be used for Health Technology Assessment (HTA) and for academic publication.
market access
A tailor made market access plan suggests an optimal market environment at launch. We identify evidence and actions to obtain optimal key drivers, such as price and reimbursement.